GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Xoma Ltd. (XOMA) [hlAlert]

XOMA is a leader in the discovery, development and manufacture of therapeutic antibodies, with a therapeutic focus that includes cancer and immune diseases. XOMA has royalty interests in RAPTIVA, a monoclonal antibody product marketed worldwide to treat moderate-to-severe plaque psoriasis, and LUCENTIS,
a monoclonal antibody product marketed worldwide to treat neovascular age-related macular degeneration. The company has built a premier antibody discovery and development platform that includes access to seven of the leading commercially available antibody phage display libraries and XOMA's proprietary Human Engineering and bacterial cell expression technologies. More than forty five companies have signed BCE licenses. XOMA's development collaborators include Lexicon Genetics, Inc., Novartis, and Schering-Plough Corporation. With a fully integrated product development infrastructure, XOMA's product development capabilities extend from preclinical sciences to product launch.
( Total: 17 Current Stock Recommendations )
Xoma Ltd.   (17)
Hold 24% Buy 76%
Related companies
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Nutraceutical ...   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
10/12/2007  
Buy
  
4/23/2008  
Buy
  
5/13/2008  
Buy
  
7/29/2008  
Buy
  
3/9/2009  
Buy
  
3/12/2009  
Hold
  
11/18/2009  
Buy
  
1/4/2011  
Buy
  
3/23/2011  
Buy
  
3/31/2011  
Buy
  
5/14/2012  
Buy
  
8/13/2013  
Buy
  
1/9/2014  
Buy
  
3/5/2014  
Hold
  
3/11/2014  
Hold
  
10/10/2014  
Buy
  
7/22/2015  
Hold
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy